The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 137,655 | 5,250 | SH | SOLE | 5,250 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 656,115 | 128,650 | SH | SOLE | 128,650 | 0 | 0 | ||
| AZENTA INC | COM | 114340102 | 247,544 | 9,700 | SH | SOLE | 9,700 | 0 | 0 | ||
| BENITEC BIOPHARMA INC | COM NEW | 08205P209 | 829,560 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
| BIOHAVEN LTD | COM | G1110E107 | 769,296 | 51,700 | SH | SOLE | 51,700 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 372,400 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 1,132,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | COM | 22978P205 | 1,670,408 | 52,928 | SH | SOLE | 52,928 | 0 | 0 | ||
| DISC MEDICINE INC | COM | 254604101 | 592,434 | 8,100 | SH | SOLE | 8,100 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 399,780 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 369,733 | 9,100 | SH | SOLE | 9,100 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,208,666 | 112,434 | SH | SOLE | 112,434 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 739,840 | 578,000 | SH | SOLE | 578,000 | 0 | 0 | ||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 274,176 | 10,200 | SH | SOLE | 10,200 | 0 | 0 | ||
| HUMACYTE INC | COM | 44486Q103 | 507,260 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| INNATE PHARMA S A | SPONSORED ADS | 45781K204 | 149,318 | 81,151 | SH | SOLE | 81,151 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 186,222 | 8,200 | SH | SOLE | 8,200 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | 291,840 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 195,765 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 504,620 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 610,170 | 5,500 | SH | SOLE | 5,500 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,098,800 | 820,000 | SH | SOLE | 820,000 | 0 | 0 | ||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 283,290 | 10,500 | SH | SOLE | 10,500 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 1,314,225 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | ||
| PACIRA BIOSCIENCES INC | COM | 695127100 | 342,495 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 1,489,816 | 4,450 | SH | SOLE | 4,450 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 318,668 | 26,600 | SH | SOLE | 26,600 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 294,120 | 86,000 | SH | SOLE | 86,000 | 0 | 0 | ||
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 1,199,898 | 21,400 | SH | SOLE | 21,400 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 512,145 | 28,500 | SH | SOLE | 28,500 | 0 | 0 | ||
| SERES THERAPEUTICS INC | COM NEW | 81750R201 | 249,087 | 31,570 | SH | SOLE | 31,570 | 0 | 0 | ||
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | 54,000 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 786,960 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 677,082 | 14,700 | SH | SOLE | 14,700 | 0 | 0 | ||
| VIATRIS INC | COM | 92556V106 | 439,876 | 27,700 | SH | SOLE | 27,700 | 0 | 0 | ||